RunX3 methylation has been detected in many premalignant lesions of gastric carcinomas, including 8.1% of chronic gastritis, 28.1% of intestinal metaplasia, 27.3% of gastric adenomas and 64% gastric carcinomas [94]. This evidence concerns the gene RUNX3 and gastric carcinoma.